UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:December 27,
Diffusion Pharmaceuticals (NASDAQ:DFFN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Diffusion Pharmaceuticals Charts.
Diffusion Pharmaceuticals (NASDAQ:DFFN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Diffusion Pharmaceuticals Charts.

Diffusion Pharmaceuticals Inc. News

Form DEF 14A - Other definitive proxy statements
Monday 29 April 2024 (2 days ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 23 April 2024 (1 week ago) • Edgar (US Regulatory)
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 11 April 2024 (3 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 5 April 2024 (4 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 4 April 2024 (4 weeks ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 29 March 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 28 March 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 18 March 2024 (1 month ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

More Diffusion Pharmaceuticals Inc. News Articles